secwatch.observer — SEC 8-K summary
======================================

Issuer:     LifeStance Health Group, Inc. (LFST)
CIK:        0001845257
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001193125-22-276872
Event type: leadership
Sentiment:  neutral
Materiality: 0.65
Item codes: 5.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

LifeStance appoints David Bourdon as CFO, J. Michael Bruff to Business Transformation Officer
--------------------------------------------------------------------------------

- David Bourdon appointed CFO effective Nov 10, 2022; succeeds J. Michael Bruff who becomes Business Transformation Officer.
- Bourdon's annual base salary $500k, target bonus 75% of base, $1M stock signing bonus subject to repayment before 4-year anniversary.
- Bourdon granted option to purchase 1.25M shares of LFST common stock; 1/3 time-based vesting over 4 years, 2/3 performance-based.
- Bruff transition: retains $1.5M sign-on bonus, surrenders ~$1M in shares, accelerated vesting of RSUs and RSAs on effective date.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1845257/000119312522276872/0001193125-22-276872-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1845257/000119312522276872/d414366d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-276872

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer